Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661804			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760860		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661805			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760861		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661806			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760862		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661807			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760863		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661808			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760864		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661809			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760865		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661810			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760866		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661811			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760867		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661812			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760868		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661813			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760869		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661814			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760870		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661815			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760871		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661774			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760873		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661775			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760872		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661776			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760875		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661777			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760874		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661778			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760877		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661779			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760876		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661780			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760879		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661781			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760878		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661782			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760881		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661783			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760880		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661784			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP13539	ES760883		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661785			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760882		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661786			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760884		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661787			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760885		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661788			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760886		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661789			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760887		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661790			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760888		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661791			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760889		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661792			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760890		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661793			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760891		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661794			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760892		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661795			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760893		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661796			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760894		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661797			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760895		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661798			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760896		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661799			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760897		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661800			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760898		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661801			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP13539	ES760899		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661802			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP13539	ES760900		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661803			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP13539	ES760901		HAI	BAYLOR_SEROLOGY_NO_TREATMENT	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		423738	HAI result	Serology_by_Cohort.423738.xlsx	Serology_by_Cohort.xlsx
